» Articles » PMID: 16336199

Protein Kinase Cepsilon Interacts with Cytochrome C Oxidase Subunit IV and Enhances Cytochrome C Oxidase Activity in Neonatal Cardiac Myocyte Preconditioning

Overview
Journal Biochem J
Specialty Biochemistry
Date 2005 Dec 13
PMID 16336199
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously identified a phorbol ester-induced PKCepsilon (protein kinase Cepsilon) interaction with the ( approximately 18 kDa) COIV [CO (cytochrome c oxidase) subunit IV] in NCMs (neonatal cardiac myocytes). Since PKCepsilon has been implicated as a key mediator of cardiac PC (preconditioning), we examined whether hypoxic PC could induce PKCepsilon-COIV interactions. Similar to our recent study with phorbol esters [Ogbi, Chew, Pohl, Stuchlik, Ogbi and Johnson (2004) Biochem. J. 382, 923-932], we observed a time-dependent increase in the in vitro phosphorylation of an approx. 18 kDa protein in particulate cell fractions isolated from NCMs subjected to 1-60 min of hypoxia. Introduction of a PKCepsilon-selective translocation inhibitor into cells attenuated this in vitro phosphorylation. Furthermore, when mitochondria isolated from NCMs exposed to 30 min of hypoxia were subjected to immunoprecipitation analyses using PKCepsilon-selective antisera, we observed an 11.1-fold increase in PKCepsilon-COIV co-precipitation. In addition, we observed up to 4-fold increases in CO activity after brief NCM hypoxia exposures that were also attenuated by introducing a PKCepsilon-selective translocation inhibitor into the cells. Finally, in Western-blot analyses, we observed a >2-fold PC-induced protection of COIV levels after 9 h index hypoxia. Our studies suggest that a PKCepsilon-COIV interaction and an enhancement of CO activity occur in NCM hypoxic PC. We therefore propose novel mechanisms of PKCepsilon-mediated PC involving enhanced energetics, decreased mitochondrial reactive oxygen species production and the preservation of COIV levels.

Citing Articles

Mitochondrial Kinase Signaling for Cardioprotection.

Boengler K, Eickelmann C, Kleinbongard P Int J Mol Sci. 2024; 25(8).

PMID: 38674076 PMC: 11049936. DOI: 10.3390/ijms25084491.


Mitochondrial phosphoproteomes are functionally specialized across tissues.

Hansen F, Kremer L, Karayel O, Bludau I, Larsson N, Kuhl I Life Sci Alliance. 2023; 7(2).

PMID: 37984987 PMC: 10662294. DOI: 10.26508/lsa.202302147.


Quantitative Proteomics Analysis Reveals That Cyclooxygenase-2 Modulates Mitochondrial Respiratory Chain Complex IV in Cardiomyocytes.

Alvarez M, Nunez E, Fuertes-Agudo M, Cucarella C, Fernandez-Velasco M, Bosca L Int J Mol Sci. 2022; 23(21).

PMID: 36362254 PMC: 9655412. DOI: 10.3390/ijms232113476.


Metabolic Remodeling and Implicated Calcium and Signal Transduction Pathways in the Pathogenesis of Heart Failure.

Chaanine A Int J Mol Sci. 2021; 22(19).

PMID: 34638917 PMC: 8508915. DOI: 10.3390/ijms221910579.


Cytochrome Oxidase at Full Thrust: Regulation and Biological Consequences to Flying Insects.

Mesquita R, Gaviraghi A, Goncalves R, Vannier-Santos M, Mignaco J, Fontes C Cells. 2021; 10(2).

PMID: 33671793 PMC: 7931083. DOI: 10.3390/cells10020470.


References
1.
Johnson J, Gray M, Chen C, Mochly-Rosen D . A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996; 271(40):24962-6. DOI: 10.1074/jbc.271.40.24962. View

2.
Johnson J, Gray M, Karliner J, Chen C, Mochly-Rosen D . An improved permeabilization protocol for the introduction of peptides into cardiac myocytes. Application to protein kinase C research. Circ Res. 1996; 79(6):1086-99. DOI: 10.1161/01.res.79.6.1086. View

3.
Goldberg M, Zhang H, Steinberg S . Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J Clin Invest. 1997; 99(1):55-61. PMC: 507767. DOI: 10.1172/JCI119133. View

4.
Randall M, Gardiner S, Bennett T . Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat. Cardiovasc Res. 1997; 33(2):400-9. DOI: 10.1016/s0008-6363(96)00210-6. View

5.
Salerno V, Ribeiro A, Dinucci A, Mignaco J, Sorenson M . Specificity and kinetic effects of nitrophenol analogues that activate myosin subfragment 1. Biochem J. 1997; 324 ( Pt 3):877-84. PMC: 1218504. DOI: 10.1042/bj3240877. View